Outbreak of Black Fungus in COVID-19 patients: An emerging issue

Authors

  • Shehroz Shahid Karachi Medical and Dental College
  • Fatima Sohail Karachi Medical and Dental College
  • Irfan Ullah Gandhara University
  • Abdul Jabbar University of Veterinary and Animal Sciences
  • Muhammad Junaid Tahir Lahore General Hospital

Keywords:

COVID-19, Mucormycosis, Corticosteroids, Emerging issue

Abstract

Not available.

Author Biographies

Shehroz Shahid, Karachi Medical and Dental College

Karachi Medical and Dental College, Karachi, Pakistan.

Fatima Sohail, Karachi Medical and Dental College

Karachi Medical and Dental College, Karachi, Pakistan.

Irfan Ullah, Gandhara University

Kabir Medical College, Gandhara University, Peshawar, Pakistan.

Abdul Jabbar, University of Veterinary and Animal Sciences

Department of Clinical Medicine, Faculty of Veterinary Science, University of Veterinary and Animal Sciences, Lahore, Pakistan.

Muhammad Junaid Tahir, Lahore General Hospital

Lahore General Hospital, Lahore, Pakistan.

References

Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. J Clinic microbio reviews. 2005;18(3):556.

Ferreira I DR, Papa G, Kemp S, Meng B, Rakshit P, et al. SARS-CoV-2 B. 1.617 emergence and sensitivity to vaccine-elicited antibodies. J bioRxiv.2021.

Mallapaty S. India’s massive COVID surge puzzles scientists. J Nature. 2021;592(7856):667-8.

Upasana K, Rastogi N, Thakkar D, Yadav A, Arora S, Yadav S. Mucormycosis Surge with the Second Wave of COVID-19 in India. J Authorea Preprints.2021.

Mohammed AH, Blebil A, Dujaili J, Rasool-Hassan BA. The Risk and Impact of COVID-19 Pandemic on Immunosuppressed Patients: Cancer, HIV, and Solid Organ Transplant Recipients. J AIDS reviews .2020;22(3):151-7.

Tandon N, Anjana RM, Mohan V, Kaur T, Afshin A, Ong K, et al. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. J The Lancet Global Health.2018;6(12):e1352-e62.

Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. J Clinical Infectious Diseases.2012;54(suppl_1):S23-S34.

Theoharides T, Conti P. Dexamethasone for COVID-19? Not so fast. J Biol Regul Homeost Agents.2020;34(3):10.23812.

Hu Z, He B, Ma L, Sun Y, Niu Y, Zeng B. Recent advances in ergosterol biosynthesis and regulation mechanisms in Saccharomyces cerevisiae. Indian journal of microbiology.2017;57(3):270-7.

Chakraborty S. The epidemic of ‘Black fungus’(mucormycosis) in Covid19 patients in India-a perfect synergy between immuno-suppressive drugs and supportive oxygen that promotes the bio-syntheses of ergosterol (a key component of fungal cell membranes)? 2021.

Published

2021-11-24

How to Cite

Shahid, S. ., Sohail, F. ., Ullah, I. ., Abdul, J., & Tahir, M. J. . (2021). Outbreak of Black Fungus in COVID-19 patients: An emerging issue. Razi International Medical Journal, 1(2). Retrieved from https://rimj.org/pubs/index.php/journal/article/view/23

Issue

Section

LETTER TO EDITOR(S)